Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. PBM
PBM logo

PBM

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

PBM News

Pacific Bay Minerals Adopts Semi-Annual Reporting

5d agoYahoo Finance

Trump Signs Order to Accelerate Psychedelic Drug Research

Apr 21 2026Newsfilter

Trump Signs Executive Order to Accelerate Psychedelic Research

Apr 21 2026stocktwits

AtaiBeckley Price Target Raised to $15 Amid Positive Drug Trial News

Apr 20 2026stocktwits

Trump Accelerates Psychedelic Research, PBM Stock Soars

Apr 20 2026stocktwits

U.S. Stock Futures Retreat Amid Renewed Geopolitical Tensions

Apr 20 2026stocktwits

Trump Administration to Examine Safety of Psychedelic Drug for PTSD

Apr 18 2026Yahoo Finance

Health Care Stocks Rise 1.4% on NYSE

Apr 17 2026Yahoo Finance

Trump to Sign Executive Order on Psychedelic Research

Apr 17 2026stocktwits

Psyence Supports U.S. Regulated Research on Ibogaine

Apr 17 2026NASDAQ.COM

Psyence BioMed Welcomes U.S. Executive Order on Ibogaine Research

Apr 17 2026Newsfilter

Israel-Lebanon Ceasefire Boosts Market Sentiment

Apr 17 2026stocktwits

Trump Confirms Israel-Lebanon Ceasefire Amid Market Optimism

Apr 17 2026stocktwits

Trump Administration to Examine Ibogaine Research for PTSD Funding

Apr 16 2026stocktwits

Psyence BioMed Expands Clinical Network to Five Sites in Australia

Apr 08 2026Newsfilter

Psyence BioMed Successfully Exports GMP-Compliant Psychedelic Product

Mar 03 2026Newsfilter